FlowAid FA100 SCCD

Advantages of the FlowAid FA100 SCCD

  • Increase patient’s Quality of Life
    Swelling and Pain greatly reduced
  • Patients Have Complete Mobility while Being Treated
    You can continue with your normal daily schedule
  • Easy to Use
    Easy to apply and simple to operate
  • Wound Healing is Accelerated
    Wound reoccurrences are prevented
  • No External Pressure to the Leg
    No pain or damage to sensitive skin


How it Works

By contracting the calf muscles, the natural mechanisms that regulate and control blood flow are activated causing increased venous outflow from the leg through the following four actions:

1. Activation of the natural venous muscle pump.

2. Forming a pattern of muscle contractions in a peristaltic wave form along the longitudinal axis from distal to proximal.

3. Activation of the musculature induces a metabolic demand creating an increased arterial inflow.

4. Chronic activation of the musculature releases natural angiogenic factors which form new blood vessels and increases muscle mass enabling a better muscle pump action.

Instructions for applying the electrodes for your FlowAid FA100 SCCD:

3 different modes of treatment of the FlowAid FA100 SCCD:

VE is indicated for the treatment of Venous Disorders.

AA  is indicated for the treatment of Arterial Disorders.

PA  is indicated for the treatment of  Peripheral Neuropathies.

The recommended treatment protocol and dosage is the same across all conditions. 2 hours twice daily to the affected limb is ideal.

The Mechanism

The primary mechanism of the Flowaid FA100 SCCD is to compress the veins in the lower leg by using specifically controlled peristaltic contractions, causing an increase in Venous Outflow from the limb. This is useful in the treatment of Chronic Venous Insufficiency, Lymphedema, and the complications of these diseases.

Secondarily, by increasing Venous Outflow, the FA100 SCCD also increases Arterial Inflow. This is useful for the treatment of PAD, Arterial Insufficiency and the complications that may develop from these conditions.

The FA100 SCCD has been useful in treating Microischemic Neuropathy by hyperperfusing the limb.